Ireland central to new EU deal on Pfizer vaccines
Posted date: 10 Jun 2021
Pfizer must manufacture vaccines and source ingredients within the European Union under a new contract signed with the The commission formally signed a contract with Pfizer and BioNTech on Thursday to secure 1.8 billion additional doses of the vaccine. The contract requires that the vaccine is produced in the EU and that “essential components are sourced from the EU”, the commission said in a statement.
The terms of the deal make Dublin’s It will be only the second plant worldwide – and the only one outside the United States – to manufacture drug substance, which is the key ingredient in the vaccine.
Pfizer is also investing in its Croatian plant in Zagreb which will manufacture other raw material for the vaccine under the new EU contract, a spokesman said. Pfizer said it was also working with outside companies – including Baxter, Sanofi and Thermo Fisher Scientific – on sterile filling of vials, packaging, cold chain storage and drug product formulation.
“The additional 900 million agreed doses are expected to be delivered on a monthly schedule beginning December 2021 and continuing into 2023,” Pfizer said in a statement. “This new agreement is in addition to the 600 million doses that have already been committed to the EU through 2021.”
Reference Link: https://www.irishtimes.com/business/health-pharma/ireland-central-to-new-eu-deal-on-pfizer-vaccines-1.4570283
Posted By
GSP Admin
